Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

What You Need to Know About Shepherd Therapeutics

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

There are many unusual things about Shepherd Therapeutics, but one of them is its origin. Source: BioSpace

Continue ReadingWhat You Need to Know About Shepherd Therapeutics

Novartis' Kymriah Snags Speedy Review From the FDA, EMA

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

Kymriah became the first CAR-T cell therapy to receive regulatory approval when it was approved by the FDA in August 2017. Source: BioSpace

Continue ReadingNovartis' Kymriah Snags Speedy Review From the FDA, EMA

Regeneron Keeps Science at the Center

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

Thirty years ago, neurologist Leonard S. Schliefer, MD, PhD, founded Regeneron, a life sciences company dedicated to discovering, developing and bringing new medications to the patients who need them. Source:…

Continue ReadingRegeneron Keeps Science at the Center

Watch Out: Cambridge Biotech Makes a Comeback

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

After a two year absence, Aveo returned to the halls of the key event with a drug newly approved for use in Europe and possibly poised for approval in the…

Continue ReadingWatch Out: Cambridge Biotech Makes a Comeback

Chinese Bidders Circle Johnson & Johnson’s $4B+ Diabetes Biz

  • Post author:Sam
  • Post published:January 16, 2018
  • Post category:BioPharma

Chinese interest in the J&J unit comes as the market for diabetes care in China is expected to grow rapidly. Source: BioSpace

Continue ReadingChinese Bidders Circle Johnson & Johnson’s $4B+ Diabetes Biz

Google Backs Vaccitech's $27M Series A Funding Round

  • Post author:Sam
  • Post published:January 14, 2018
  • Post category:BioPharma

Vaccitech is an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products. Source: BioSpace

Continue ReadingGoogle Backs Vaccitech's $27M Series A Funding Round

What You Need to Know About Corbin Therapeutics

  • Post author:Sam
  • Post published:January 14, 2018
  • Post category:BioPharma

Corbin Therapeutics, headquartered in Montreal, Quebec, was spun out of venture capital company AmorChem. Source: BioSpace

Continue ReadingWhat You Need to Know About Corbin Therapeutics

5 Tasty Takeover Targets for 2018

  • Post author:Sam
  • Post published:January 14, 2018
  • Post category:BioPharma

Many investors and analysts expect that the changes to the corporate tax code will lead to increased merger and acquisition activity in 2018. Source: BioSpace

Continue Reading5 Tasty Takeover Targets for 2018

Rigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch

  • Post author:Sam
  • Post published:January 14, 2018
  • Post category:BioPharma

The U.S. Food and Drug Administration is set to rule on Tavalisse (fostamatinib disodium), an oral spleen tyrosine kinase (SYK) inhibitor, for adult patients with chronic or persistent immune thrombocytopenia…

Continue ReadingRigel Pharma Awaits FDA Approval for Tavalisse, Builds Commercial Org for Drug Launch

U.S. Asset Manager Wants in On China Biotech Unicorn Innovent Biologics' $200M+ IPO

  • Post author:Sam
  • Post published:January 14, 2018
  • Post category:BioPharma

The Suzhou-based cancer-drug maker has been discussing a valuation of more than $1 billion. Source: BioSpace

Continue ReadingU.S. Asset Manager Wants in On China Biotech Unicorn Innovent Biologics' $200M+ IPO
  • Go to the previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.